Irradiated Human Fibroblasts as a Substitute Feeder Layer to Irradiated Mouse 3T3 for the Culture of Human Corneal Epithelial Cells: Impact on the Stability of the Transcription Factors Sp1 and NFI.
NFI
Sp1
feeder layer
gene profiling
human corneal epithelial cells
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Dec 2019
13 Dec 2019
Historique:
received:
18
10
2019
revised:
03
12
2019
accepted:
09
12
2019
entrez:
19
12
2019
pubmed:
19
12
2019
medline:
29
4
2020
Statut:
epublish
Résumé
Because of the worldwide shortage of graftable corneas, alternatives to restore visual impairments, such as the production of a functional human cornea by tissue engineering, have emerged. Self-renewal of the corneal epithelium through the maintenance of a sub-population of corneal stem cells is required to maintain the functionality of such a reconstructed cornea. We previously reported an association between stem cell differentiation and the level to which they express the transcription factors Sp1 and NFI. In this study, we investigated the impact of replacing irradiated 3T3 (i3T3) murine fibroblast feeder cells by irradiated human corneal fibroblasts (iHFL) on the expression of Sp1 and NFI and evaluated their contribution to the proliferative properties of human corneal epithelial cells (hCECs) in both monolayer cultures and human tissue engineered corneas (hTECs). hCECs co-cultured with iHFL could be maintained for up to two more passages than when they were grown with i3T3. Western Blot and electrophoretic mobility shift assays (EMSAs) revealed no significant difference in the feeder-layer dependent increase in Sp1 at both the protein and DNA binding level, respectively, between HCECs grown with either i3T3 or iHFL. On the other hand, a significant increase in the expression and DNA binding of NFI was observed at each subsequent passage when hCECs were co-cultured along with i3T3. These changes were found to result from an increased expression of the NFIA and NFIB isoforms in hCECs grown with i3T3. Exposure of hCECs to cycloheximide revealed an increased stability of NFIB that likely resulted from post-translational glycosylation of this protein when these cells were co-cultured with i3T3. In addition, iHFL were as efficient as i3T3 at preserving corneal, slow-cycling, epithelial stem cells in the basal epithelium of the reconstructed hTECs. Furthermore, we observed an increased expression of genes whose encoded products promote hCECs differentiation along several passages in hCECs co-cultured with either type of feeder layer. Therefore, the iHFL feeder layer appears to be the most effective at maintaining the proliferative properties of hCECs in culture most likely by preserving high levels of Sp1 and low levels of NFIB, which is known for its gene repressor and cell differentiation properties.
Identifiants
pubmed: 31847118
pii: ijms20246296
doi: 10.3390/ijms20246296
pmc: PMC6940969
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : MOP-12087
Pays : Canada
Références
Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1447-57
pubmed: 12657578
Invest Ophthalmol Vis Sci. 1993 May;34(6):1991-9
pubmed: 8387976
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2362-7
pubmed: 9122200
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3490-505
pubmed: 17652716
EBioMedicine. 2017 Aug;22:2-9
pubmed: 28596133
Biomaterials. 2016 Feb;78:86-101
pubmed: 26686051
Cell. 1989 Apr 21;57(2):201-9
pubmed: 2702690
Science. 1999 Dec 10;286(5447):2169-72
pubmed: 10591651
Cell. 2016 Jul 14;166(2):328-342
pubmed: 27374332
J Periodontol. 2007 Sep;78(9):1795-802
pubmed: 17760551
J Pathol. 2019 Feb;247(2):186-198
pubmed: 30350349
J Gerontol A Biol Sci Med Sci. 2013 Aug;68(8):914-25
pubmed: 23292286
Methods Mol Biol. 2013;989:119-42
pubmed: 23483392
Nature. 2013 Mar 7;495(7439):98-102
pubmed: 23389444
Nucleic Acids Res. 2006;34(22):6472-87
pubmed: 17130157
JAMA Ophthalmol. 2016 Feb;134(2):167-73
pubmed: 26633035
J Mol Biol. 2012 May 18;418(5):281-99
pubmed: 22420942
Methods Mol Biol. 2019;1879:43-73
pubmed: 29804261
Biochemistry. 2002 Oct 22;41(42):12771-84
pubmed: 12379120
Br J Ophthalmol. 2009 Feb;93(2):263-7
pubmed: 19174402
FASEB J. 1997 Nov;11(13):1067-75
pubmed: 9367342
J Cell Physiol. 2006 Mar;206(3):831-42
pubmed: 16245313
Cell Rep. 2016 Jul 19;16(3):631-43
pubmed: 27373156
Clin Ophthalmol. 2018 Jun 07;12:1049-1059
pubmed: 29922034
Cell. 1988 Oct 7;55(1):125-33
pubmed: 3139301
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3742-55
pubmed: 12939287
Ophthalmology. 2011 Aug;118(8):1524-30
pubmed: 21571372
J Biol Chem. 2002 Jul 19;277(29):25893-903
pubmed: 11991954
BMC Mol Biol. 2007 Oct 25;8:96
pubmed: 17961220
Ann N Y Acad Sci. 2010 Jun;1197:166-77
pubmed: 20536846
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Exp Eye Res. 2018 Nov;176:161-173
pubmed: 30003884
Tissue Eng Part A. 2013 Apr;19(7-8):1023-38
pubmed: 23173810
Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E584-91
pubmed: 12900380
Nat Protoc. 2015 Jun;10(6):823-44
pubmed: 25950236
Sci Rep. 2018 Aug 10;8(1):11955
pubmed: 30097586
Oncotarget. 2017 Oct 17;8(55):94666-94680
pubmed: 29212257
Pathobiology. 1999 May-Jun;67(3):140-7
pubmed: 10394135
J Biol Chem. 2001 Jan 5;276(1):662-9
pubmed: 11024050
Prog Retin Eye Res. 2000 Sep;19(5):497-527
pubmed: 10925241
Mol Cell Biol. 1997 May;17(5):2550-8
pubmed: 9111324
J Cancer. 2017 Jul 20;8(12):2282-2295
pubmed: 28819432
Br J Ophthalmol. 2012 May;96(5):614-8
pubmed: 22133988
Curr Eye Res. 1996 Sep;15(9):973-84
pubmed: 8921219
Genes Dev. 2011 Jul 15;25(14):1470-5
pubmed: 21764851
Cancer Lett. 2017 Dec 1;410:124-138
pubmed: 28962832
Int J Mol Sci. 2013 Feb 26;14(3):4684-704
pubmed: 23443166
J Virol. 2011 Sep;85(17):9247-8
pubmed: 21697491
J Biol Chem. 2000 Dec 15;275(50):39182-92
pubmed: 10995740
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9523-8
pubmed: 15983386
Biotechniques. 1991 Dec;11(6):770-7
pubmed: 1809334
Exp Eye Res. 2006 Oct;83(4):741-6
pubmed: 16720021
Mol Vis. 2010 Oct 29;16:2192-201
pubmed: 21139684
Cell Tissue Res. 2018 Dec;374(3):531-540
pubmed: 30091046
Biochem Biophys Res Commun. 2008 Jul 18;372(1):1-13
pubmed: 18364237
Exp Eye Res. 2007 Dec;85(6):772-81
pubmed: 17904552
Br J Ophthalmol. 2011 Jul;95(7):942-6
pubmed: 21097786
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3758-67
pubmed: 18421093
Biochem Biophys Res Commun. 2007 Jul 6;358(3):770-6
pubmed: 17511965
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1376-85
pubmed: 18385053
Nat Med. 2005 Feb;11(2):228-32
pubmed: 15685172
Cornea. 2002 Oct;21(7 Suppl):S54-61
pubmed: 12484700